Tumour-infiltrating lymphocytes (TILs) are a good predictive and prognostic biomarker in human epidermal growth factor receptor 2 (HER2)-positive breast cancer, where abundant TILs in the stroma of invasive breast carcinoma is an independent marker for good prognosis. The gene discussed is ERBB2; the disease is breast carcinoma.